Skip to search formSkip to main contentSkip to account menu

HZT-501

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Reducing the incidence of peptic ulcers with ibuprofen-famotidine combined pill, HZT-501 (reduce): phase-III, double-blind multi-centre trials
Introduction The prevention of peptic ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs) is hampered by the high… 
2010
2010
HZT-501, a Novel Combination Tablet of Ibuprofen and Famotidine, Provides Pharmacokinetics Comparable to European Commercially Available Ibuprofen in a Patient-Friendly Dosing Form: Evaluation in…
HZT-501, a Novel Combination Tablet of Ibuprofen and Famotidine, Provides Pharmacokinetics Comparable to European Commercially… 
2010
2010
T1137 HZT-501, a Novel Combination Tablet of Ibuprofen and Famotidine, Provides Pharmacokinetics Comparable to Commercially Available Ibuprofen in a Patient-Friendly Dosing Form: Evaluation in…
Review
2009
Review
2009
407 Does High-Dose Famotidine Reduce Gastric and Duodenal Ulcers in NSAID Users? Two Double-Blind Six-Month Trials of Single-Tablet Combination Ibuprofen-Famotidine vs. Ibuprofen Alone (Reduce-1 and…
Review
2009
Review
2009
408 Increased Aspirin Use and Upper Gastrointestinal Bleeding Rates in Socially Deprived Patients
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)